ENTITY

Tempus AI (TEM US)

31
Analysis
Health Care • United States
Tempus AI, Inc. operates as a clinical laboratory. The Company provides genomic sequencing services and analyze molecular and therapeutic data to help physicians to make real-time and data-driven decisions.Tempus AI serves customers in the United States.
more
Exchange Announcement • 03 Oct 2026 04:14

S-4/A | Registration of securities issued in business combination transactions (Amendment)

Exchange Announcement • 16 Sep 2026 05:25

425 | Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Exchange Announcement • 01 Sep 2026 04:32

S-4 | Registration of securities issued in business combination transactions

Exchange Announcement • 31 Jul 2026 04:01

Current Report (Form 8-K | Period ending 2026-07-30)

Exchange Announcement • 30 Jul 2026 08:00

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

x